These results show that individual neurons that do not express the transgene but are exposed to the challenge of tau uptake, phosphorylation, and aggregation, show changes in synaptic and metabolic mRNAs that are reminiscent of what has been observed in human AD. Here, MAPT is linked to Alzheimer disease.